HCPCS Code J9025: Injection, Azacitidine, 1 mg

Yes, J9025 can be billed in both settings as long as the administration and dosage are properly documented.

Yes, patients may experience nausea, vomiting, anemia, neutropenia, or thrombocytopenia, which should be documented and managed.

Many payers require prior authorization for azacitidine therapy, especially for non-FDA-labeled indications, so verify with the insurer first.